1. Home
  2. OLMA vs PAYS Comparison

OLMA vs PAYS Comparison

Compare OLMA & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • PAYS
  • Stock Information
  • Founded
  • OLMA 2006
  • PAYS 2001
  • Country
  • OLMA United States
  • PAYS United States
  • Employees
  • OLMA N/A
  • PAYS N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • PAYS Business Services
  • Sector
  • OLMA Health Care
  • PAYS Consumer Discretionary
  • Exchange
  • OLMA Nasdaq
  • PAYS Nasdaq
  • Market Cap
  • OLMA 299.7M
  • PAYS 125.2M
  • IPO Year
  • OLMA 2020
  • PAYS 1998
  • Fundamental
  • Price
  • OLMA $4.65
  • PAYS $7.88
  • Analyst Decision
  • OLMA Strong Buy
  • PAYS Strong Buy
  • Analyst Count
  • OLMA 4
  • PAYS 4
  • Target Price
  • OLMA $24.50
  • PAYS $7.06
  • AVG Volume (30 Days)
  • OLMA 825.6K
  • PAYS 1.1M
  • Earning Date
  • OLMA 08-05-2025
  • PAYS 08-05-2025
  • Dividend Yield
  • OLMA N/A
  • PAYS N/A
  • EPS Growth
  • OLMA N/A
  • PAYS N/A
  • EPS
  • OLMA N/A
  • PAYS 0.11
  • Revenue
  • OLMA N/A
  • PAYS $63,792,627.00
  • Revenue This Year
  • OLMA N/A
  • PAYS $30.03
  • Revenue Next Year
  • OLMA N/A
  • PAYS $20.14
  • P/E Ratio
  • OLMA N/A
  • PAYS $71.65
  • Revenue Growth
  • OLMA N/A
  • PAYS 26.77
  • 52 Week Low
  • OLMA $2.86
  • PAYS $1.80
  • 52 Week High
  • OLMA $16.62
  • PAYS $8.57
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 52.46
  • PAYS 85.08
  • Support Level
  • OLMA $4.38
  • PAYS $4.72
  • Resistance Level
  • OLMA $5.01
  • PAYS $8.57
  • Average True Range (ATR)
  • OLMA 0.30
  • PAYS 0.50
  • MACD
  • OLMA 0.05
  • PAYS 0.12
  • Stochastic Oscillator
  • OLMA 63.64
  • PAYS 95.89

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.

Share on Social Networks: